Commentary: Combination Treatment Using Favipiravir for Crimean-Congo Hemorrhagic Fever
DOI:
https://doi.org/10.51094/jxiv.1594Keywords:
Crimean-Congo hemorrhagic fever, favipiravir, tetracycline, Kampo medicineAbstract
Crimean-Congo hemorrhagic fever virus is a tick-borne bunyavirus that causes Crimean-Congo hemorrhagic fever, characterized by acute febrile illness and rapid progress to severe hemorrhage manifestations with a high mortality rate. No specific antiviral drugs have been approved for the treatment of Crimean-Congo hemorrhagic fever. Favipiravir, a broad-spectrum antiviral drug originally developed for influenza, is known to inhibit the activity of RNA-dependent RNA polymerase of various RNA viruses. Recently, favipiravir demonstrated in vivo efficacy against Crimean-Congo hemorrhagic fever virus in animal models. For the purpose of promptly finding effective drugs for Crimean-Congo hemorrhagic fever, drug repurposing has been proposed. Especially, computational screening through in silico studies offer a cost-effective and time-efficient approach to identifying potential drug candidates for repurposing. This approach demonstrated that tetracycline and the phytochemical skullcapflavone I, are efficacious against Crimean-Congo hemorrhagic fever virus. Scutellaria, which contains skullcapflavone I in its extracts, is a component of the Kampo medicines Sho-saiko-to and Saiko-keishi-to. In the near future, the aforementioned drugs may be recognized as Crimean-Congo hemorrhagic fever virus inhibitors. Furthermore, considering the synergistic effects of drugs, a combination of favipiravir and tetracycline, or a combination of favipiravir and Kampo medicine may be more effective.
Conflicts of Interest Disclosure
I declare that there are no conflicts of interest in connection with this paper.Downloads *Displays the aggregated results up to the previous day.
References
References
Oestereich L, Rieger T, Neumann M, Bernreuther C, Lehmann M, Krasemann S, Wurr S, Emmerich P, de Lamballerie X, Ölschläger S, Günther S. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS neglected tropical diseases. 2014 May 1;8(5):e2804.
Dülger AC, Yakarişik M, Uzun YE, Şahin AM. Treatment of Crimean-Congo haemorrhagic fever by favipiravir in a patient with novel coronavirus co-infection. European Journal of Case Reports in Internal Medicine. 2020 Dec 17;7(12):002042.
Álvarez-Rodríguez B, Tiede C, Hoste AC, Surtees RA, Trinh CH, Slack GS, Chamberlain J, Hewson R, Fresco A, Sastre P, Tomlinson DC. Characterization and applications of a Crimean-Congo hemorrhagic fever virus nucleoprotein-specific Affimer: Inhibitory effects in viral replication and development of colorimetric diagnostic tests. PLoS Neglected Tropical Diseases. 2020 Jun 3;14(6):e0008364.
Sharifi A, Amanlou A, Moosavi-Movahedi F, Golestanian S, Amanlou M. Tetracyclines as a potential antiviral therapy against Crimean Congo hemorrhagic fever virus: Docking and molecular dynamic studies. Computational Biology and Chemistry. 2017 Oct 1;70:1-6.
Hirano M, Sakurai Y, Urata S, Kurosaki Y, Yasuda J, Yoshii K. A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus. Antiviral Research. 2022 Apr 1;200:105276.
Ohe M, Shida H, Yamamoto J, Seki M, Furuya K. Successful treatment with minocycline and Saiko-keishi-to for COVID-19. J Clin Exp Investig. 2023;14(2):em00815.
Ohe M, Shida H, Yamamoto J, Seki M, Furuya K, Nishio S. COVID-19 Treated with Minocycline and Saiko-keishi-to: A Case Report. International Med J. 2024 Feb 1;31(1):27-8.
Ohe M, Tsuchida N. Treatment with Kampo Medicine and Minocycline for Influenza. Preprints 2025, 2025011957. https://doi.org/10.20944/preprints202501.1957.v1
Ohe, M. Drug Repurposing with Minocycline and Japanese Kampo Medicine for MPox: Predicting Efficacy Through In Silico Studies. Preprints 2024, 2024091128. https://doi.org/10.20944/preprints202409.1128.v1
Ramzan M, Mahmood S, Amjad A, Javed M, Zidan A, Bahadur A, Iqbal S, Saad M, Zaka N, Khurshid S, Awwad NS. Finding potential inhibitors from phytochemicals against nucleoprotein of Crimean-Congo fever virus using in silico approach. Scientific Reports. 2024 Dec 30;14(1):31804.
Downloads
Posted
Submitted: 2025-10-04 12:19:58 UTC
Published: 2025-10-14 07:48:15 UTC
License
Copyright (c) 2025
Masashi Ohe

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.